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Ribosomal surveillance pathways scan for ribosomes that are transiently paused or 
terminally stalled due to structural elements in mRNAs or nascent chain (NC) sequences1,2. 
Some stalls in budding yeast are sensed by the GTPase Hbs1 (see Fig. 1a for human 
orthologs), which loads Dom34, a catalytically-inactive member of the archaeo-eukaryotic 
Release Factor 1 (aeRF1) superfamily. Hbs1•Dom34 and the ATPase Rli1 dissociate stalled 
ribosomes into 40S and 60S subunits. However, the 60S subunits retain the peptidyl-tRNA 
NCs, which recruit the ribosome quality control (RQC) complex comprised of 
Rqc1•Rqc2•Ltn1•Cdc48•Ufd1•Npl4. NCs ubiquitylated by the E3/ubiquitin ligase Ltn1 are 
extracted from the 60S by the ATPase Cdc48•Ufd1•Npl4 and presented to the 26S 
proteasome for degradation3–9. Failure to degrade the NCs leads to protein aggregation and 
proteotoxic stress in yeast and neurodegeneration in mice10–14. Despite intensive 
investigations on the RQC pathway, it is not known how the tRNA is hydrolyzed from the 
ubiquitylated NC prior to its degradation. Here we show that the Cdc48 adaptor Vms1 is a 
peptidyl-tRNA hydrolase. Similar to classical eRF1, Vms1 activity is dependent on a 
conserved catalytic glutamine. Evolutionary analysis indicates that yeast Vms1 is the 
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founding member of a clade of eRF1 homologs that we designate the Vms1-like RF1 clade 
(VLRF1).
Yeast Cdc48, a AAA+ ATPase that is conserved across eukaryotes and archaea, is a protein 
unfoldase15,16 that engages in myriad cellular functions through binding of adaptors such as 
Ufd1•Npl4 (UN), which bind both Cdc48 and ubiquitylated substrate proteins. A protein A-
based ‘non-stop’ substrate reporter (PrANS) encoded by an mRNA lacking a stop codon 
(Fig. 1b) accumulates on the ribosomal 60S subunit as a ubiquitylated species linked to 
tRNA when Cdc48 or UN function is compromised7, suggesting that Cdc48•UN somehow 
extracts ubiquitylated NC from the 60S tunnel6–8.
Two pieces of evidence implicated Vms1, which contains a Cdc48-binding VIM motif17,18, 
in the RQC pathway. First, vms1Δ and RQC-deficient mutations cause a synthetic growth 
defect when combined with mutations that impair degradation of non-stop mRNA8,19. 
Second, vms1Δ18 mutants, like rqc2Δ20, are cycloheximide-sensitive. We extended this by 
showing that vms1Δ, like ltn1Δ and cdc487, displayed striking sensitivity to hygromycin, 
which binds the decoding center (Extended Data Fig. 1a).
To investigate further the role of Vms1 in degradation of non-stop proteins, we examined 
PrANS levels. PrANS conjugated to tRNA (PrANS-tRNA) accumulated in vms1Δ, but not 
in mutants lacking other Cdc48 adaptors (Fig. 1c). Additionally, vms1Δ accumulated high 
molecular weight (HMW) forms of PrANS. Treatment with RNase or deubiquitylase 
enzymes (Extended Data Fig. 1c) and pull-downs with ubiquitin-binding TUBE resin 
(Extended Data Fig. 1d) confirmed that HMW PrANS species were tRNA-linked ubiquitin 
conjugates (Ub-PrANS-tRNA).
Splitting of stalled 80S ribosomes is a prerequisite for stable association of Ltn1 with 60S 
subunits. Ltn1 then ubiquitylates the NCs prior to their degradation by 26S proteasomes21. 
To determine if Ub-PrANS-tRNA accumulated on 60S subunits in vms1Δ, we fractionated 
cell lysates on sucrose gradients. Immunoblotting for PrANS and the 60S protein Rpl3 
revealed that Ub-PrANS-tRNA accumulated maximally in the first few Rpl3-containing 
fractions, which marks the position of 60S subunits (Fig. 1d)7. By contrast, non-
ubiquitylated PrANS-tRNA that accumulated in both vms1Δ and vmsΔltn1Δ cells was 
enriched on 80S subunits and polysomes. These data confirm that Ub-PrANS-tRNA 
accumulated on 60S subunits in vms1Δ in a manner that was dependent on Ltn1.
If Vms1 is directly involved in releasing stalled PrANS, it should bind ribosomes. To 
investigate this prediction, we immunoblotted sucrose gradient fractions from cells 
expressing Vms1 tagged with a triple HA epitope (Vms1HA3). Whereas Ltn1 is restricted to 
60S fractions4, Vms1HA3 was detected across the entire gradient (Fig. 1e). This behavior 
suggests a broader function for Vms1 beyond its role in the RQC pathway. Interestingly, the 
60S peak of Vms1HA3 was diminished and shifted towards lighter fractions in ltn1Δ cells 
(Fig. 1e), suggesting that in addition to Cdc48•UN6, Ltn1 also promotes recruitment of 
Vms1 to 60S subunits. However, unlike Cdc48•UN, Vms1 was not identified as a 
component of RQC complex6. Consistent with this, Vms1 did not associate directly with UN 
(Extended Data Figs. 1e–h).
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Given the exceptionally strong accumulation of PrANS-tRNA in vms1Δ, we wondered if 
Vms1 might have any relationship to known peptidyl-tRNA hydrolases. We carried out 
sensitive iterative sequence profile searches with PSI-BLAST and hidden Markov models 
seeded with the core RNaseH fold domain of the archaeal and eukaryotic RF1 proteins and 
the catalytically inactive Dom34 proteins, which are both members of the archaeo-
eukaryotic RF1 (aeRF1) superfamily (see Methods). Strikingly, these searches recovered the 
central globular region of Vms1 orthologs. Reciprocal PSI-BLAST searches with this region 
recovered several members of the aeRF1 superfamily. This relationship was emphatically 
confirmed with a profile-profile comparison using the HHpred program with an alignment of 
the central conserved region of aeRF1 run against the PDB database, which significantly 
recovered 1DT9 (human eRF1; p-value=4 × 10−5). This showed that the central domain of 
Vms1 had a putative catalytic loop bearing a conserved glutamine (Q) comparable to the 
classic active site of aeRF1s (Figs. 2a, b). An aeRF1-like architecture was observed in the 
recently reported crystal structure of the middle domain of Vms1, but the putative active site 
loop was not resolved22. The conserved glutamine in the eRF1 protein coordinates a water 
molecule in the A-site at the peptidyl transferase center (PTC). Nucleophilic attack of the 
peptidyl-tRNA in the P site by this water molecule releases the completed polypeptide 
chain23,24. In addition to the putative active site glutamine, Vms1 also contains conserved 
vicinal arginines in the α-helix immediately following the active site loop (Figs. 2a, b). 
Equivalent arginines in eRF1 have been implicated in stabilization of the active site loop23, 
and stimulation of GTPase eRF325. Based on this striking confluence of similarities we 
designated Vms1 as the founding member of the Vms1-Like Release Factor-1 (VLRF1) 
clade within the aeRF1 superfamily. In addition to the eukaryotic orthologs of Vms1 the 
VLRF1 clade also contains members from certain bacteria, predominantly bacteroidetes and 
more divergent versions in certain Archaea (Extended Data Figs. 2a, b).
To determine if Vms1 indeed is a novel peptidyl-tRNA hydrolase we generated two separate 
point mutations (Q295L, Q295P) of the predicted catalytic glutamine, which abrogate eRF1 
function in budding yeast23 and bacterial RFs26, respectively. We also generated a putative 
active site deletion mutant (ΔAS). All mutant proteins were expressed normally and bound 
ribosomes (Fig. 3a). Whereas wild type Vms1HA3 rescued vms1Δ, cells expressing the point 
mutants accumulated PrANS-tRNA (Fig. 3a left panel), which sedimented with ribosomes 
(middle panel) and was conjugated to Ub (right panel). Sucrose gradient fractionation 
confirmed that Ub-PrANS-tRNA accumulated on 60S subunits in cells expressing 
Vms1HA3-Q295L (Fig. 3b). Remarkably, the mutant protein strongly accumulated on 60S 
subunits, and was depleted from low MW fractions (Fig. 3c). Consistent with their 
biochemical defect, the vms1-Q295L, -Q295P, and -ΔAS mutants were exquisitely sensitive 
to hygromycin and cycloheximide (Fig. 3d). The point mutants thus phenocopy vms1Δ, both 
genetically and biochemically.
The putative catalytic region of Vms1 and other VLRF1 proteins is flanked by additional N- 
and C-terminal domains. The N-terminal C2H2-Zinc finger of Vms1 is specifically related 
to those of Rei1 and certain SBDS paralogs, which function at late steps in 60S subunit 
maturation27. This suggests that Vms1 might contact the ribosome with its Rei1-like Zn-
finger domain (Fig. 2c). Meanwhile, the Vms1 C-terminal region is characterized by a run of 
3 ankyrin repeats, a treble-clef fold Zn-binding domain (VTC; lost in fungi) and a VIM 
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motif that binds Cdc4817,18 (Fig. 2c). To probe the role of these other sequence features, we 
generated mutants including ‘DNKR’ (lacking four Rei1-like Zn-finger residues predicted to 
interact with 60S; see legend for details), ‘RR’ (lacking the conserved vicinal arginines in 
the catalytic domain), and ‘ΔVIM’, and expressed the proteins in a vms1Δ strain. All mutant 
proteins were expressed comparably to wild type (Extended Data Fig. 3a). To assess the 
effects of the mutations we performed sucrose gradient fractionation of ribosomes. 
Compared to vms1Δ rescued by wildtype VMS1HA3, all mutants accumulated Ub-PrANS-
tRNA in 60S fractions (Extended Data Fig. 3c). The ‘RR’ mutant exhibited the strongest 
accumulation, as well as conspicuous spreading of Ub-PrANS-tRNA into the 80S peak, 
which was also observed with the ΔVIM mutant. Interestingly, the ‘DNKR’ mutant protein 
was shifted to lighter fractions, with depletion from monosome and polysome fractions, 
consistent with a role for the zinc finger in binding ribosomes (Extended Data Fig 3d). 
Notably, the cycloheximide sensitivity of the various mutants mimics the data obtained with 
the reporter, with the ΔAS and ‘RR’ mutants being most sensitive (Extended Data Fig. 3b).
To address conclusively the hypothesis that Vms1 is a novel peptidyl-tRNA hydrolase, we 
sought to reconstitute peptidyl-tRNA hydrolytic activity in vitro. Wildtype and His6Vms1-
Q295L were expressed in bacteria and purified (Extended Data Fig. 4a). For substrate, we 
employed 60S fractions from vms1Δ cells expressing PrANS. His6Vms1 and substrate were 
mixed and following incubation, peptidyl-tRNA was precipitated using CTAB. His6Vms1 
promoted release of both Ub-PrANS-tRNA and PrANS-tRNA species from 60S subunits 
(Fig. 4a). In sharp contrast, His6Vms1-Q295L was unable to release modified substrate. This 
assay was reproducible but required extensive manipulations that resulted in spontaneous 
hydrolysis of the substrate during its preparation. In addition, it was difficult to reliably 
quantify heterogeneous Ub conjugates by immunoblot. Therefore, we turned to in vitro 
translation in rabbit reticulocyte lysate, which has been used to reconstitute ubiquitylation of 
RQC substrates9,21. These earlier studies demonstrated that ubiquitylation of the NC is 
delayed ~15 minutes following translation. Because the Vms1-dependent reaction (Fig. 4a) 
did not display strong dependence on substrate ubiquitylation, we ran brief translation 
reactions with a non-stop template encoding FlagCRP with a 30 nucleotide polyA tail to 
generate stalled NCs that had not yet been ubiquitylated, which simplified quantification. 
The major translation product (Fig. 4b) was confirmed by CTAB precipitation and RNase 
treatment to be tRNA-conjugated FlagCRPNSKn (Extended Data Fig. 4b). Consistent with a 
prior report9, the stalled FlagCRPNSKn-tRNA was associated maximally with 80S fractions 
(Extended Data Fig. 4c).
To assay for eRF1-like peptidyl-tRNA hydrolytic activity, wildtype or mutant His6Vms1 was 
incubated with [35S]-labeled substrate for increasing time (Fig. 4b). De-acylation of 
FlagCRPNSKn-tRNA with concomitant formation of unmodified substrate was observed 
within three minutes (Figs. 4b, c) and at concentrations as low as 25 nM His6Vms1 (Fig. 4d, 
quantified in Extended Data Fig. 4d), whereas essentially no hydrolysis above background 
was observed with His6Vms1-Q295L. Since recombinant yeast Vms1 was functional in this 
heterologous system, we next tested Ankzf1, the human Vms1 ortholog. Purified Ankzf1 
(Extended Data Fig. 4a) catalyzed deacylation, whereas the active site mutant Ankzf1-
Q246L was inactive (Fig. 4e and Extended Data Fig. 4e).
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Like vms1Δ, cdc48 mutant cells accumulate Ub-PrANS-tRNA on 60S subunits7. This raises 
the question, what is the role of Cdc48 in hydrolysis of peptidyl-tRNA? We were unable to 
establish ATP-dependence for the in vitro deacylation reaction (not shown), which perhaps 
is not surprising because ATPase Rli1 accelerates NC release by eRF1 in the presence of 
non-hydrolyzable ATP5. We suggest that Cdc48 facilitates presentation of the catalytic 
glutamine of Vms1 at the PTC, much as Rli1 positions eRF1 in canonical termination28. A 
scaffolding function could account for accumulation of ubiquitylated reporter in 60S and 
80S fractions in vms1-ΔVIM mutants (Extended Data Fig. 3c). Cdc48 ATPase working 
jointly with Ltn1 may play an additional role at the exit tunnel post-deacylation. The 
emerging NC is ubiquitylated by Ltn1 which recruits Cdc48•UN6,7. The latter can 
translocate along and unfold the NC15,16 thereby ensuring its extraction from the 60S 
subunit. In other contexts, different factors may facilitate NC clearance. For example, 
defective ribosome-NC complexes targeted to mitochondria become stuck during import29. 
Vms1 promotes clearance of these stalls in a VIM-independent manner. Due to close 
apposition of the stalled ribosome-NC and mitochondrial translocon29, neither Ltn1 nor 
Cdc48•UN should gain access to the deacylated NC to ensure its extraction. Vms1 also 
localizes to the ER and the RQC pathway can rescue NC stalled at the Sec61 translocon30.
Three observations point to an additional role for Vms1 in release of stalled NC-tRNA from 
intact ribosomes, which is also likely to be Ltn1-independent: (i) Vms1 associates with all 
forms of ribosomes and this persists in ltn1Δ (Fig. 1e), (ii) vms1 mutant cells exhibited 
strong accumulation of PrANS-tRNA in both monosome and polysome fractions (Figs. 1d 
and 3b), and (iii) Low doses (Fig. 4d) of Vms1 rapidly (Fig. 4b) deacylated 80S-associated 
peptidyl-tRNA; note however that NC-engaged 60S subunits can re-associate with free 40S 
subunits in vitro to generate 80S RNCs21.
We suggest that in vivo, the “leading” stalled ribosome on non-stop poly (A) mRNA with 
the A site occupied could be the monosome substrate for Vms1 (see Extended Data Fig. 5 
for model). Cleavage by an unidentified endonuclease generates ribosomes on truncated 
mRNA with empty A sites that are known to be rescued by Dom34•Hbs1•Rli11. Jammed 
NC-tRNA on these split 60S subunits is ubiquitylated by Ltn1 and the tRNA linkage is 
hydrolyzed by Vms1. Our discovery of Vms1 as the founding member of the VLRF1 clade 
reveals that multiple different functional peptidyl-tRNA hydrolase release factors belonging 
to the aeRF1 superfamily coexist in eukaryotic cells. We posit that VLRF1 and Dom34 
evolved to protect the translation apparatus from errors in transcription and post-
transcriptional processing that generate defective mRNAs.
Methods
Yeast strains and culture conditions
All strains used in the current study are listed in Extended Data Table 1. They were derived 
from the W303 or S288C backgrounds and grown as described in Verma et al.7
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Western Blot Analyses
Antibodies used were: Peroxidase Anti-Peroxidase Soluble Complex (PAP; used to detect 
Protein A, Sigma, # P1291). Anti-Flag M2 (Sigma # F-1804), anti-TAP (Thermo Fisher # 
CAB1001, and anti-HA 3F10 (Roche/Sigma # 12013819001). Anti-Rpl32 and Rpl3 were a 
gift from Jonathan Warner.
Ribosome isolation and sub-fractionation
Sucrose cushion method for isolation of ribosomes, binding of ribosomal preparations to 
TUBE-UBA resin, sucrose density gradient centrifugation, and CTAB precipitation of 
peptidyl-tRNA from sucrose gradient fractions were performed as described previously in 
Verma et al.7 TUBE resin was from Boston Biochem, # AM-130. CTAB 
(Hexadecyltrimethyl-ammonium bromide) was from Sigma (# 52365).
Site-Directed Mutagenesis
All expression constructs for mutational analysis were generated using the Q5-Site-Directed 
Mutagenesis Kit (NEB #E00554S) following the manufacturer’s manual. Primers were 
designed using the online tool NEBaseChanger (http://nebasechanger.neb.com). Mutations 
were confirmed by Sanger Sequencing. All plasmids are listed in Table 1.
Purification of His6Vms1 and His6Vms1-Q295L from bacteria
Wildtype and mutant Vms1 (Extended Data Table 1) were cloned into the bacterial pET-28a 
vector in frame with the N-terminal His6 tag. Expression was induced in Rosetta cells using 
1mM IPTG at 16°C for 16 hours. Cell pellets were brought up in lysis buffer containing 
50mM Hepes, pH 8.0, 0.5M NaCl, 20mM Imidazole and 0.5% Triton, sonicated, and 
centrifuged at 17,000 rpm for 20 min in a Sorvall SS34 rotor. Supernatant was bound to Ni-
NTA affinity resin (Qiagen) for 1 hour at 4°C. Bound proteins were washed 4X in lysis 
buffer and eluted in 25mM Hepes, pH 7.5, 150mM NaCl, 5% glycerol and 250mM 
Imidazole. Imidazole was removed by dialysis and protein concentrated using Amicon Ultra 
centrifugal filters.
Purification of Ankzf1FlagMyc and Ankzf1FlagMyc-Q246L—Plasmids were 
constructed that contained the CMV promoter followed by sequences encoding wild type 
(Origene) or Q246L Ankzf1 (current study; confirmed by sequencing) tagged with a 
FlagMyc epitope at the 3’ end of the open reading frame. These constructs were transiently 
transfected into human embryonic kidney HEK293 cells (ATCC, tested negative for 
mycoplasma contamination; DTC # 264). After 72 hours, proteins were purified by virtue of 
the Flag epitope using the protocol for Flag-tagged mammalian proteins reported by Shao et 
al.21.
In vitro Transcription and Translation
PCR products were generated using 3XFlag-CRP (Extended Data Table 1) as template with 
reverse primer either containing a stop codon (3XFlag-CRPStop), or lacking a stop codon 
but with a 30 nucleotide polyT extension (3XFlag-CRPNSKn). PCR products were 
transcribed and translated in vitro using TnT T7 Quick rabbit reticulocyte lysate (Promega, # 
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L5540) in the presence of radioactive methionine (Perkin Elmer, #NEG709A). Reactions 
were typically for 30 mins at 30°C, at which time recombinant proteins were added for 
another 10 mins. Aliquots were resolved by SDS-PAGE, and dried gels were either exposed 
to film or to a PhosphorImager screen.
Isolation of TAP-tagged complexes from yeast
Cells in which CDC48, VMS1, or UFD1 were tagged at the 3’ end with the Tandem Affinity 
Purification (TAP) epitope31 were grown to exponential phase in 2 L YPD medium and 
harvested. Washed cell pellets were ground in liquid nitrogen, and resuspended in 0.5× the 
volume of powder in a lysis buffer containing 25mM Tris, pH 7.5, 150mM NaCl, 0.25% 
Triton and protease inhibitor tablets (Roche, # 11873580001). Following centrifugation at 
17000 rpm for 20 minutes (Sorvall SS34 rotor), lysates were bound to 200 ul acid-washed 
IgG sepharose 6 Fast Flow (GE Healthcare, # 17-0969-01) at 4°C for 90 mins. Bound 
proteins were washed 2× in lysis buffer, 2× in TEV buffer (25mM Tris, pH 7.5, 150 mM 
NaCl, 2mM DTT, 5% glycerol) and eluted by cleavage with 50 units TEV for 2 hours at 
16°C.
Mass spectrometry analyses
Eluted samples were lyophilized and digested for mass spectrometry analysis as described in 
Pierce et al.32 Approximately 250ng of trypsin-digested peptides were loaded onto a 26-cm 
analytical HPLC column (75 µm inner diameter) packed in-house with ReproSil-Pur C18AQ 
1.9-µm resin (120-Å pore size; Dr. Maisch, Ammerbuch, Germany). Once loaded, the 
peptides were separated with a 120-min gradient at a flow rate of 350 nl/min at 50°C 
(column heater) using the following gradient: 2–6% solvent B (7.5 min), 6–25% B (82.5 
min), 25–40% B (30 min), 40–100% B (1 min), and 100% B (9 min), where solvent A was 
97.8% H2O, 2% ACN, and 0.2% formic acid, and solvent B was 19.8% H2O, 80% ACN, 
and 0.2% formic acid. Samples were analyzed using an EASY-nLC 1000 coupled to an 
Orbitrap Fusion operated in data-dependent acquisition mode to automatically switch 
between a full scan (m/z = 350–1500) in the Orbitrap at 120,000 resolving power and an 
MS/MS scan of higher-energy collisional dissociation fragmentation detected in the ion trap 
(using TopSpeed). The automatic gain control (AGC) targets of the Orbitrap and ion trap 
were 400,000 and 10,000, respectively.
Mass Spec Data analysis
All raw data were searched concurrently using MaxQuant (version 1.5.3.30;33,34) against the 
Saccharomyces Genome Database (SGD) and a common contaminant database. Precursor 
mass tolerance was 4.5 ppm after automatic recalibration. Fragment ion tolerance was 0.5 
Da. Searches permitted up to two missed tryptic peptide cleavages. Cysteine 
carbamidomethylation was designated as a fixed modification while Methionine oxidation 
and N-terminal acetylation were designated as variable modifications. iBAQ protein 
quantification and “match between runs” were enabled. Protein and peptide false discovery 
rates were estimated to be <1% using a target-decoy approach.
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Computational Analyses
Iterative sequence profile searches were performed using the PSI-BLAST35 and 
JACKHMMER36 programs run against the NCBI non-redundant protein database (nr) 
clustered at 50% identity using the MMseqs2 program. Similarity-based clustering for both 
classification and culling of nearly identical sequences was performed using the 
BLASTCLUST program (ftp://ftp.ncbi.nih.gov/blast/documents/blastclust.html). The length 
(L) and score (S) threshold parameters were variably adjusted depending on need. For 
example, the length (L) and score (S) threshold parameters for clustering near identical 
proteins was L = 0.9 and S = 1.2. The HHpred program was used for profile-profile 
searches37. Structure similarity searches were performed using the DaliLite program38. 
Multiple sequence alignments were made using the Kalign program followed by manual 
adjustments on the basis of profile-profile and structural alignments39. Secondary structures 
were predicted using the JPred program40. For previously known domains, the Pfam 
database41 was used as a guide, though the profiles were augmented by addition of newly 
detected divergent members that were not detected by the original Pfam models. Clustering 
with BLASTCLUST followed by multiple sequence alignment and further sequence profile 
searches were used to identify other domains that were not present in the Pfam database. 
Contextual information from prokaryotic gene neighborhoods was retrieved by a Perl script 
that extracts the upstream and downstream genes of the query gene and uses BLASTCLUST 
to cluster the proteins to identify conserved gene-neighborhoods. Phylogenetic analysis was 
conducted using an approximately-maximum-likelihood method implemented in the 
FastTree 2.1 program under default parameters42. Structural visualization and manipulations 
were performed using the PyMol 1.8.2.0 (Open Source; http://www.pymol.org) program.
Data Availability
Gel source images for Figs. 1, 3, 4 and Extended Data Figs. 1, 3 and 4 are available in 
Supplementary Fig. 1. Source data for quantifications in Figs. 4 and Extended Data Fig. 4 
are provided in the online version of the paper. All other data supporting the findings of this 
study are available from the corresponding authors upon reasonable request.
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Extended Data
Extended Data Figure 1. Mass spectrometric analysis of Vms1 required for release of Ub-
PrANS-tRNA from ribosomes
a, Serial 10-fold dilutions of exponential cultures were spotted on YPD plates with or 
without 100µg/ml Hygromycin B and allowed to grow at 30°C for 3 days. Data shown is 
representative of 3 biological replicates. b, Ponceau S stained nitrocellulose filter used as 
loading control for Fig. 1c. c, Lysate from vms1Δ cells expressing PrANS (Input, lane 5) 
was fractionated on a sucrose gradient and 60S fractions were pooled and mock-treated 
(lanes 1, 3) or pretreated with the deubiquitylating enzyme Usp2c (1µM; lane 2) or 100 
µg/ml RNase A (lane 4) at 30°C for 20 minutes prior to CTAB precipitation. The pellets 
were IB with PAP. d, Ribosomes from the indicated strains were isolated using sucrose 
cushions and aliquots were IB to detect PrANS and Rpl3. The remainder was bound to 
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TUBE resin. The adsorbed fractions were IB with PAP. All lanes of the left and right panels 
are from the same blots. The dashed lines indicate cropping of lanes not pertinent to the 
current study. Gel source uncropped data are shown in Supplementary Fig.1. Data in c and d 
are representative of two biological replicates. e–h, Mass spectrometric analysis of TAP-
tagged Cdc48, Vms1 and Ufd1. e, Relative abundance of each Cdc48 adapter co-
immunoprecipitated with Cdc48 relative to all adapter proteins identified. f, Schematic 
illustrating the estimated stoichiometry of Cdc48●adapter complexes. g, Relative 
stoichiometry of associated proteins co-immunoprecipitated with Cdc48, Vms1 and Ufd1. 
Samples were normalized to the iBAQ value of the bait protein and presented as percent of 
bait protein. Protein iBAQ values from the untagged control was subtracted from the tagged 
immunoprecipitation samples. h, Coomassie blue stained gel of samples used for mass spec 
analysis. All mass spec data (e–h) are representative of two biological replicates.
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Extended Data Figure 2. Vms1 is the founding member of the VLRF1 clade
a, Extended sequence alignment of aeRF1 superfamily with representatives from all 
families/clades (compared to the limited subset in Fig. 2a). b, Phylogenetic tree depicting 
relationships within the aeRF1 superfamily; coloring matches clade labels in Fig. 2a. In the 
classical aeRF1 clade two branches respectively contain eukaryotic orthologs (eRF1) and 
archaeal orthologs (aRF1). Of the bacterial (baeRF1) versions, certain members are 
misannotated as “Host_attach” in the Pfam database while most cannot be detected by 
existing profiles. The total number of prokaryotic representatives of the VLRF1 clade in the 
non-redundant database (NCBI, Dec 1, 2017) is 1044. Of these the archaeal VLRF1 family 
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(aVLRF1) has 279, actino-chloroflexi VLRF1 family (acVLRF1) has 669 and the 
bacteroidetes VLRF1 family (bVLRF1) has 96 representatives. Notable domain 
architectures and conserved gene neighborhoods are shown to the right of tree. A gene 
encoding a ribosome hibernation factor (HPF1/YfiA) that facilitates inactive ribosome 
aggregation, frequently co-occurs and is predicted to function with the baeRF1 domains. 
Labels below name the well-characterized clade representatives, PDB structure IDs, and 
phyletic distributions. Dashed outline indicates domain is not universally present.
Extended Data Figure 3. Mutagenesis of the non-catalytic domains of Vms1
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a, SDS lysates of the cells used in c below were IB with anti-HA. Ponceau S staining of blot 
shows equivalency of extracts. b, Serial 10 -fold dilutions of WT and vms1Δ cells 
transformed with the indicated vms1 alleles were spotted on YPD plates containing 10 or 25 
ng/ml cycloheximide and incubated at 30°C for 3 days. Data are representative of three 
biological replicates. c, Native lysates (10 A260 units each) were subjected to sucrose 
gradient analysis. In each case fractions 10–23 were resolved and IB to detect PrA and Rpl3. 
Identical exposures are shown for all panels. The RR mutant is R313AR314A. The DNKR 
mutant contains the following four mutations in the Zn-finger domain: D94A, N99A, 
K101A, and R102A. The ΔVIM mutant is deleted for amino acids 622–625. d, Native 
lysates of vms1Δ cells expressing wildtype Vms1HA3 or Vms1HA3-DNKR were subjected to 
sucrose gradient analysis. Fractions were IB for Vms1 and Rpl3. (MW: molecular weight 
standards). All Western blot data are representative of two biological replicates. Gel source 
data: Supplementary Fig. 1.
Extended Data Figure 4. In vitro reconstitution of Vms1 peptidyl-tRNA hydrolase activity
a, Coomassie Blue stained gels of indicated purified proteins used for in vitro reconstitution. 
b, Analysis of ribosome-nascent chain complexes generated by translation in reticulocyte 
lysate. PCR products encoding FLAGCRPNS followed by a 30 nucleotide polyA sequence 
and FLAGCRPStop (with a stop codon) were transcribed and translated in reticulocyte lysate 
in the presence of 35S-methionine. Completed translation reactions were treated as described 
below, fractionated by SDS-PAGE, and visualized by autoradiography. Lane 1: no treatment; 
lane 2: +RNase A; lane 3: treated with CTAB; lane 4: immunoprecipitated with anti-FLAG 
resin. For lanes 3 and 4, the pellet fraction was analyzed. c, Sucrose gradient analysis of 
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reticulocyte translation reactions. FLAGCRPNSKn was transcribed and translated in 200 µl 
reticulocyte lysate. Following 30 mins of translation, lysates were layered onto 2 ml 10–
50 % sucrose gradients and centrifuged using a Beckman SW55 rotor for 80 mins. 11 
fractions (200 µl each) were collected from the top by hand. Aliquots were analyzed for 
fractionation of 35S-labeled substrate and Rpl8 by autoradiography and IB, respectively. d, 
Quantification of two independent biological replicates of yeast His6Vms1 and His6Vms1-
Q295L titration reactions shown in Fig. 4d. e, Quantification of titrations of human Ankzf1 
and Ankzf1-Q246L shown in Fig. 4e. Representative of two biological replicates. All gel 
image and quantification source data in Supplementary Fig. 1.
Extended Data Fig. 5. Working model of Vms1 function at stalled ribosomes
In non-stop decay of mRNAs lacking a stop codon, ribosomes translate the poly(A) tail and 
stall after translating several lysines4,19. The A site as a consequence is occupied by a AAA 
codon. Our data suggest that Vms1 can potentially hydrolyze peptidyl-tRNA chains on this 
leading stalled ribosome without prior splitting by Dom34•Hbs1•Rli1. One of the known 
responses to stalling is endonucleolytic cleavage of the mRNA by an as-yet unidentified 
endonuclease. The cleavage reaction generates a truncated transcript. Lagging ribosomes 
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that translate up to the cleavage site stall with an empty A site. Such stalls are recognized by 
Dom34•Hbs1 that together with Rli1 dissociate the 80S into 40S and 60S containing the 
nascent peptidyl-tRNA1. Dissociation allows for stable association of the RQC complex 
members Rqc1•Rqc2 and the E3 ubiquitin ligase Ltn19. Rqc2 adds non-templated Ala and 
Thr residues to the C-terminal end of the NC to extrude sequences in the exit tunnel past the 
active site of Ltn1, which ubiquitylates Lys residues in the emerging nascent chain10 and 
with the aid of Cdc48, optimizes the conformation of Vms1 at the PTC such that it can 
hydrolyze the tRNA. The ubiquitylated nascent chain is engaged by Ufd1/Npl4 bound to 
Cdc48 that together unfold and extract the NC. Dissociation of Rqc2 enables access of 
Vms1 to the 60S subunit29, resulting in hydrolysis of the peptidyl-tRNA. Cdc48•Ufd1•Npl4 
recruited to the ubiquitylated NC7 ensures its efficient extraction from the 60S subunit. 
Regarding the action of Vms1 on 80S ribosomes, it is unclear if this activity is coupled in 
some manner to ribosome splitting.
Extended Data Table 1
Saccharomyces cerevisiae cell lines and Plasmids used.
RJD Number Alias Source Genotype
6689 S288C Open Biosystems his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, a
5970 S288C pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
[pGAL-ProteinA-nonstop-PGK3’UTR-
URA3]. a
6646 ubx3 Δ pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
ubx3::KANMX, [pGAL-ProteinA-
Nonstop-PGK3’UTR-URA3], a
6647 ubx4 Δ pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
ubx4::KANMX, [pGAL-ProteinA-
Nonstop-PGK3’UTR-URA3], a
6648 ubx5Δ pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
ubx5::KANMX, [pGAL-ProteinA-
Nonstop-PGK3’UTR-URA3], a
6654 ufd2Δ pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
ufd2::KANMX, [pGAL-ProteinA-
Nonstop-PGK3’UTR-URA3], a
6651 ufd3Δ pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
ufd3::KANMX, [pGAL-ProteinA-
Nonstop-PGK3’UTR-URA3], a
6640 vms1Δ pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [pGAL-ProteinA-
nonstop-PGK3’UTR-URA3], a
5510 Itn1Δ pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
Itn::KANMX, [pGAL-ProteinA-
nonstop-PGK3’UTR-URA3], a
6670 ufd1-1 pProtein A Nonstop This Study his4-519, ura3-52, ade1-100, leu2-3, 
112, ufd1-1, TRP+, pGAL-ProteinA-
nonstop-PGK3’UTR-URA3]
6722 Itn1Δ vms1Δ pProtein A Nonstop This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, Itn1::KANMX, 
[pGAL-ProteinA-nonstop-PGK3’UTR-
URA3], a
6771 vms1Δ Itn1Δ pVMS1-HA This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, Itn1::KANMX, 
[YCplac111-VMS1-3HA], a
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RJD Number Alias Source Genotype
5445 vms1 Δ Open Biosystems his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, a
5400 Itn1Δ Open Biosystems his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
Itn1::KANMX, a
6698 vms1Δ pVMS1 HA This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [YCplac111-
VMS1-3HA], a
6732 vms1Δ pvms1 Q295L HA This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [YCPlac111-vms1-
Q295LΔ-3HA], a
6701 vms1Δ pProtein A Nonstop VMS1-
HA
This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [pGAL-ProteinA-
nonstop-PGK3’UTR-URA3], 
[YCplac111-VMS1-3HA], a
6705 vms1Δ pProtein A Nonstop vms1-
Q295L-3HA
This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [pGAL-ProteinA-
nonstop-PGK3’UTR-URA3], 
[YCplac111-vms1-Q295L-3HA], a
6733 vms1Δ pvms1 Q295P This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [YCPlac111-vms1-
Q295PΔ-3HA], a
6731 vms1Δ pVMS1 ASΔ 3HA This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [YCPlac111-vms1-
ActiveSiteΔ-3HA], a
6740 vms1Δ pvms1 Δ622-625 (vimΔ) 
3HA
This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [YCplac111-vms1-
Δ622-625-3HA], a
6739 vms1Δ pvms1 ΔIntR 3HA This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [YCplac111-vms1-
ΔIntR-3HA], a
6738 vms1Δ pvms1RR3 13/314AA This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [YCplac111-vms1-
RR313/314-3HA], a
6707 vms1Δ pProtein A Nonstop pvms1 
ASΔ 3HA
This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vms1::KANMX, [pGAL-ProteinA-
nonstop-PGK3’UTR-URA3], 
[YCplac111-vms1-ASΔ-3HA], a
6706 vms1Δ pProtein A Nonstop pvms1-
Q295P-3HA
This Study his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, 
vins1::KANMX, [pGAL-ProteinA-
nonstop-PGK3’UTR-URA3], 
[YCplac111-vms1-Q295P-3HA], a
Plasmid Relevant Vector Source
RDB2764 pGAL-ProteinA-nonstop-PGK3'UTR[URA3] Ambro Van Hoof
RDB3226 YCplac111-VMS1-3HA Alexander Buchberger
RDB3293 YCplac111-vms1 ΔAA74-102-HA This Study
RDB3295 YCplac111-vms1 Δlnt R-HA This Study
RDB3286 YCplac111-vms1 ASΔ-HA This Study
RDB3287 Ycplac-111-vms1 Q295L-HA This Study
RDB3288 YCplac111-vms1 Q295P-HA This Study
RDB3292 YCplac111-vms1 RR3 13/3 14AA This Study
RDB2632 pET28a-VMS1 Hai Rao
RDB3336 pET28a-vms1 Q295L This Study
RDB3353 pCMV6-ANKZF1-mycDDK Origene
RDB3359 pCMV6-ankzf1 Q246L-mycDDK This Study
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Plasmid Relevant Vector Source
RDB3299 T7-3xFLAG-CRP This Study
Upper Table: List of yeast strains used in this study.
Lower Table: Plasmids used in this study.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Vms1 is required for release of ubiquitylated, tRNA-linked non-stop protein A reporter 
(Ub-PrANS-tRNA) from 60S ribosomal subunits
a, Mammalian orthologs of the yeast RQC pathway. b, Model substrate reporter used to 
study the non-stop pathway. c, Mutants were lysed in denaturing SDS, fractionated on a 
NuPAGE gel, and immunoblotted (IB) with PAP to detect PrA. d, Native lysates (10 A260 
units) were separated on sucrose gradients and fractions were resolved on TG gels and IB 
with PAP and anti-Rpl3. (MW: molecular weights 250, 150, 50, and 23 kDa indicated by 
marks). e, Native lysates from wild type (WT: LTN1) and ltn1Δ mutant cells expressing 
Vms1HA3 were fractionated on sucrose gradients and IB with anti-HA and Rpl3. All 
Western blots are representative of two biological replicates. Gel source data: Supplementary 
Fig. 1.
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Figure 2. Vms1 is a member of the aeRF1 superfamily and the founding member of the VLRF1 
clade
a, Multiple sequence alignment of the aeRF1 superfamily; families indicated on the right 
with accession numbers, organism abbreviations, and gene names on the left. Residues 
colored per consensus conservation, key residues and features marked at top (‘*’: catalytic 
glutamine, ‘^’: arginine residues conserved across multiple families, “&”: arginine 
conserved in VLRF1 family). b, Topology diagram of aeRF1 RNase H fold domain, key 
features labeled. c, Domain architectures of proteins containing the Rei1 C2H2-Zinc finger.
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Figure 3. Point mutations in the conserved, putative peptidyl-tRNA hydrolase active site of Vms1 
phenocopy vms1Δ
a, Schematic of experimental design. Brown circles: Ub, green: tRNA. Left panel: lysates 
from vms1Δ cells expressing either WT Vms1HA3 or the active site mutants were 
fractionated on a NuPAGE gel, and IB to detect PrA and Vms1HA3. Hexokinase (HK) served 
as loading control. ΔAS lacks amino acids 283–314. Ribosomes (middle panel) were 
isolated on sucrose cushions, and aliquots IB to detect PrA, Rpl3, and Vms1HA3. Right 
panel: the remaining ribosomes were adsorbed to TUBE resin and bound fractions were 
resolved by TG gels and IB to detect PrA. b, Native lysates (10 A260) from vms1Δ 
expressing PrANS and either WT Vms1HA3 (left panel) or the Q295L mutant (right panel) 
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were fractionated on sucrose gradients and IB to detect PrA and Rpl3. (MW: 36 and 23kDa). 
c, Sucrose gradient fractions from vms1Δ expressing Vms1-Q295LHA3 were IB to detect 
mutant Vms1 and Rpl3. They were run at the same time as WT Vms1HA3 in Fig. 1e and the 
exposures are identical. d, Serial 10-fold dilutions of WT and vms1Δ cells transformed with 
the indicated vms1 alleles were spotted on YPD plates containing 100µg/ml hygromycin or 
25 ng/ml cycloheximide and incubated at 30°C for 3 days. A representative of three 
biological replicates is shown. All Western blots are representative of two biological 
replicates. Gel source data: Supplementary Fig. 1.
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Figure 4. Peptidyl-tRNA hydrolase activity of Vms1 and Ankzf1 depend on the catalytic 
glutamine residue
a, Experimental design on left. Brown circles: Ub, green: tRNA. Lysate from vms1Δ cells 
expressing PrANS was fractionated on a sucrose gradient, and 60S fractions were pooled 
and pelleted.. His6Vms1 or His6Vms1-Q295L were added and incubated for 10 mins at 30°C. 
Ub-PrANS-tRNA was precipitated with CTAB, and IB with PAP to detect PrA. Bottom 
panel is shorter exposure (S.E.) of top from which the discrete peptidyl-tRNA band was 
quantified (Lane 5 contained additional 1mM GTP). Western blot is representative of two 
biological replicates. b, Time course of deacylation reaction using ribosome–NC complexes 
(RNCs) generated by in vitro translation. FlagCRPNSKn was translated in reticulocyte lysate 
in the presence of35S methionine for 30 minutes at 30°C. Recombinant WT or mutant 
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His6Vms1 (150 nM) was added for the indicated time periods to RNCs (75–100 nM). 
Aliquots were visualized by autoradiography. c, Phosphorimager quantification of two 
independent biological replicates from b. WT: His6Vms1. Q295L: mutant His6Vms1. d, 
Titration of Vms1. Reactions and processing as in b. e, WT and mutant hAnkzf1 were 
analyzed as described in b, except that the hydrolase reaction was performed at 37°C. A 
representative of two biological replicates is shown. Gel source image data: Supplementary 
Fig. 1.
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